Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 January 2020 | Story Lacea Loader

During meetings between the management of the University of the Free State (UFS) and the Bloemfontein Campus Student Representative Council (CSRC) the week of 27 January 2020, the following was agreed:

For 2020, students on the three campuses of the UFS who receive funding from the National Student Financial Aid Scheme (NSFAS) and who live in accredited and non-accredited accommodation, will receive the monthly accommodation allowance.

Registered NSFAS beneficiaries must log in on Self Service and apply online for the private accommodation allowance. The application process requires that the lease agreement should be uploaded. This lease agreement must be signed by both the student and the service provider. Approved private accommodation applicants will receive their private accommodation allowance payment during the first week of each month for a period of 10 months, depending on the date of approval and the rental period.

If the service provider does not have a lease agreement, students can download a basic lease agreement form. This form must be signed by the student and the service provider.

A process will be in place to verify the accommodation during 2020, as required by the Department of Higher Education, Science and Technology (DHET).  This process will start with the completion of the application form for accreditation by the service provider. 

Service providers must complete and submit the application form for accreditation to the division Housing and Residence Affairs (HRA) by 29 February 2020, to enable HRA to start the verification process as required by the DHET.

Steps for accreditation of off-campus accommodation

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept